As a uremic toxin, indoxyl sulfate is highly expressed in the serum of end-stage renal disease (ESRD) patients [39] and has been reported to cause vascular damage through the TNF-α/CX3CL1 axis [21]. Here, TNF is linked to stage 5 chronic kidney disease.